ENVIVA INC (EVA) Fundamental Analysis & Valuation

NYSE:EVA • US29415B1035

0.4198 USD
+0.01 (+2.22%)
Last: Oct 3, 2024, 08:11 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This EVA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

EVA gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 207 industry peers in the Oil, Gas & Consumable Fuels industry. EVA may be in some trouble as it scores bad on both profitability and health. EVA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. EVA Profitability Analysis

1.1 Basic Checks

  • In the past year EVA has reported negative net income.
  • In the past year EVA has reported a negative cash flow from operations.
EVA Yearly Net Income VS EBIT VS OCF VS FCFEVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 0 100M -100M -200M -300M

1.2 Ratios

  • The Return On Assets of EVA (-11.74%) is worse than 89.00% of its industry peers.
  • EVA has a worse Return On Equity (-109.62%) than 93.30% of its industry peers.
Industry RankSector Rank
ROA -11.74%
ROE -109.62%
ROIC N/A
ROA(3y)-3.96%
ROA(5y)-2.25%
ROE(3y)-28.14%
ROE(5y)-16.14%
ROIC(3y)N/A
ROIC(5y)N/A
EVA Yearly ROA, ROE, ROICEVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 -20 -40

1.3 Margins

  • EVA's Gross Margin of 1.44% is on the low side compared to the rest of the industry. EVA is outperformed by 84.21% of its industry peers.
  • EVA's Gross Margin has declined in the last couple of years.
  • EVA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 1.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.71%
GM growth 5Y-15.21%
EVA Yearly Profit, Operating, Gross MarginsEVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 10 -10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. EVA Health Analysis

2.1 Basic Checks

  • EVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for EVA has been increased compared to 1 year ago.
  • Compared to 1 year ago, EVA has an improved debt to assets ratio.
EVA Yearly Shares OutstandingEVA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M
EVA Yearly Total Debt VS Total AssetsEVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • EVA has an Altman-Z score of 0.16. This is a bad value and indicates that EVA is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 0.16, EVA is not doing good in the industry: 71.29% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 5.83 is on the high side and indicates that EVA has dependencies on debt financing.
  • With a Debt to Equity ratio value of 5.83, EVA is not doing good in the industry: 93.30% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 5.83
Debt/FCF N/A
Altman-Z 0.16
ROIC/WACCN/A
WACC3.08%
EVA Yearly LT Debt VS Equity VS FCFEVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 500M 1B 1.5B

2.3 Liquidity

  • EVA has a Current Ratio of 1.42. This is a normal value and indicates that EVA is financially healthy and should not expect problems in meeting its short term obligations.
  • EVA's Current ratio of 1.42 is in line compared to the rest of the industry. EVA outperforms 59.33% of its industry peers.
  • A Quick Ratio of 1.06 indicates that EVA should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.06, EVA is in line with its industry, outperforming 54.07% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 1.06
EVA Yearly Current Assets VS Current LiabilitesEVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. EVA Growth Analysis

3.1 Past

  • EVA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -68.50%.
  • Looking at the last year, EVA shows a decrease in Revenue. The Revenue has decreased by -0.20% in the last year.
  • Measured over the past years, EVA shows a quite strong growth in Revenue. The Revenue has been growing by 15.04% on average per year.
EPS 1Y (TTM)-68.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-936.36%
Revenue 1Y (TTM)-0.2%
Revenue growth 3Y16.93%
Revenue growth 5Y15.04%
Sales Q2Q%-1.55%

3.2 Future

  • EVA is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -3.17% yearly.
  • EVA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.60% yearly.
EPS Next Y-148.2%
EPS Next 2Y6.01%
EPS Next 3Y14.13%
EPS Next 5Y-3.17%
Revenue Next Year-6.05%
Revenue Next 2Y1.19%
Revenue Next 3Y11.72%
Revenue Next 5Y10.6%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
EVA Yearly Revenue VS EstimatesEVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
EVA Yearly EPS VS EstimatesEVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -2 -4

More info and screens

Find the best growth stocksShow best growing peers

0

4. EVA Valuation Analysis

4.1 Price/Earnings Ratio

  • EVA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EVA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EVA Price Earnings VS Forward Price EarningsEVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, EVA is valued a bit more expensive than 79.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 94.98
EVA Per share dataEVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • EVA's earnings are expected to grow with 14.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.01%
EPS Next 3Y14.13%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EVA Dividend Analysis

5.1 Amount

  • EVA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

EVA Fundamentals: All Metrics, Ratios and Statistics

ENVIVA INC

NYSE:EVA (10/3/2024, 8:11:14 PM)

0.4198

+0.01 (+2.22%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)09-13
Earnings (Next)10-30
Inst Owners57.12%
Inst Owner Change0%
Ins Owners21.27%
Ins Owner Change0%
Market Cap31.43M
Revenue(TTM)1.13B
Net Income(TTM)-339.70M
Analysts45
Price Target4.08 (871.89%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend3.3
Dividend Growth(5Y)6.05%
DP-32.32%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-143.34%
Min EPS beat(2)-288.14%
Max EPS beat(2)1.47%
EPS beat(4)1
Avg EPS beat(4)-199.08%
Min EPS beat(4)-288.14%
Max EPS beat(4)1.47%
EPS beat(8)1
Avg EPS beat(8)-988.96%
EPS beat(12)2
Avg EPS beat(12)-666.21%
EPS beat(16)4
Avg EPS beat(16)-503.85%
Revenue beat(2)0
Avg Revenue beat(2)-5.65%
Min Revenue beat(2)-9.42%
Max Revenue beat(2)-1.88%
Revenue beat(4)0
Avg Revenue beat(4)-16.16%
Min Revenue beat(4)-43.89%
Max Revenue beat(4)-1.88%
Revenue beat(8)1
Avg Revenue beat(8)-12.45%
Revenue beat(12)2
Avg Revenue beat(12)-9.32%
Revenue beat(16)3
Avg Revenue beat(16)-8.99%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B 0.1
P/tB 0.15
EV/EBITDA 94.98
EPS(TTM)-4.23
EYN/A
EPS(NY)-1.58
Fwd EYN/A
FCF(TTM)-4.42
FCFYN/A
OCF(TTM)-0.84
OCFYN/A
SpS15.11
BVpS4.14
TBVpS2.75
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -11.74%
ROE -109.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 1.44%
FCFM N/A
ROA(3y)-3.96%
ROA(5y)-2.25%
ROE(3y)-28.14%
ROE(5y)-16.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.71%
GM growth 5Y-15.21%
F-Score3
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 5.83
Debt/FCF N/A
Debt/EBITDA 111.49
Cap/Depr 207.35%
Cap/Sales 23.69%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.42
Quick Ratio 1.06
Altman-Z 0.16
F-Score3
WACC3.08%
ROIC/WACCN/A
Cap/Depr(3y)226.42%
Cap/Depr(5y)192.31%
Cap/Sales(3y)21.08%
Cap/Sales(5y)16.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-936.36%
EPS Next Y-148.2%
EPS Next 2Y6.01%
EPS Next 3Y14.13%
EPS Next 5Y-3.17%
Revenue 1Y (TTM)-0.2%
Revenue growth 3Y16.93%
Revenue growth 5Y15.04%
Sales Q2Q%-1.55%
Revenue Next Year-6.05%
Revenue Next 2Y1.19%
Revenue Next 3Y11.72%
Revenue Next 5Y10.6%
EBIT growth 1Y43.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1305.49%
EBIT Next 3Y202.11%
EBIT Next 5Y141.9%
FCF growth 1Y-88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-167.89%
OCF growth 3YN/A
OCF growth 5YN/A

ENVIVA INC / EVA FAQ

What is the ChartMill fundamental rating of ENVIVA INC (EVA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to EVA.


Can you provide the valuation status for ENVIVA INC?

ChartMill assigns a valuation rating of 0 / 10 to ENVIVA INC (EVA). This can be considered as Overvalued.


What is the profitability of EVA stock?

ENVIVA INC (EVA) has a profitability rating of 1 / 10.


Can you provide the financial health for EVA stock?

The financial health rating of ENVIVA INC (EVA) is 2 / 10.